日本患者对安慰剂抗生素的接受情况:对抗菌药物耐药性的一种处方

Patients' acceptance of placebo antibiotics in Japan: a prescription for antimicrobial resistance.

作者信息

Ito Atsushi, Watanabe Yuichi, Okumura Takashi

机构信息

Faculty of Public Policy, Kyoto Prefectural University, Kyoto City, Kyoto, Japan.

Faculty of Health and Welfare Services Administration, Kawasaki University of Medical Welfare, Kurashiki City, Okayama, Japan.

出版信息

J Pharm Policy Pract. 2022 Nov 8;15(1):79. doi: 10.1186/s40545-022-00470-8.

Abstract

BACKGROUND

The generalized use of antibiotics has led to the emergence of bacteria which are resistant to antimicrobial agents. This stems in part from the patient's tendencies to seek antibiotics for diseases when not necessary. Hence, this article investigated patient acceptance of prescribing placebos as a substitute for unnecessary antibiotics in Japan, where physicians are under severe time constraints and are unable to offer explanations and persuade patients who demand unnecessary antibiotics prescription.

METHODS

A web-based questionnaire was administered to assess patients' acceptance of the placebo treatment under informed consent. One thousand participants representing all genders and age-class were randomly selected from the online panel of a web-survey company.

RESULTS

The results showed that 67.9% of the participants were "satisfied" to receive such treatments, whereas 20.6% indicated acceptance of the prescription but without satisfaction. In total, 88.5% of the participants accepted the prescription of placebo, a result consistent with that of a preceding study on placebo treatments conducted in the United States. In the survey, tone of persuasion did not affect the patients' attitudes; however, patients who were loyal to their physicians exhibited lower refusal rates.

CONCLUSION

The survey results showed that the prescription of "ethical placebos" could be an acceptable option for the patients in Japan. For ethical concerns, an additional literature survey was conducted and the result suggested that such a radical treatment option could be justified, provided that the prescription benefits patients and informed consent is properly obtained. Albeit it is impractical to use, because of ethical and operational concerns, it would be worth further investigation to ensure diversity in the countermeasures for antimicrobial resistance, a major public health threat nowadays.

摘要

背景

抗生素的广泛使用导致了对抗菌药物产生耐药性的细菌的出现。这部分源于患者在不必要时倾向于寻求抗生素来治疗疾病。因此,本文调查了在日本患者对开具安慰剂替代不必要抗生素的接受程度,在日本,医生面临严重的时间限制,无法对要求开具不必要抗生素处方的患者进行解释和劝说。

方法

通过网络问卷来评估患者在知情同意下对安慰剂治疗的接受程度。从一家网络调查公司的在线样本中随机选取了1000名代表所有性别和年龄组的参与者。

结果

结果显示,67.9%的参与者“满意”接受此类治疗,而20.6%的参与者表示接受处方但不满意。总体而言,88.5%的参与者接受安慰剂处方,这一结果与之前在美国进行的一项关于安慰剂治疗的研究结果一致。在调查中,劝说的语气并未影响患者的态度;然而,对医生忠诚的患者拒绝率较低。

结论

调查结果表明,开具“符合伦理的安慰剂”处方对日本患者来说可能是一个可接受的选择。出于伦理考虑,进行了额外的文献调查,结果表明,只要处方对患者有益且能正确获得知情同意,这种激进的治疗选择是合理的。尽管由于伦理和操作方面的考虑,使用起来不切实际,但为确保应对当今主要公共卫生威胁——抗菌药物耐药性的措施具有多样性,值得进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索